We are live on ! Find out more
TPST icon

Tempest Therapeutics
TPST

35 hedge funds and large institutions have $5.89M invested in Tempest Therapeutics in 2018 Q3 according to their latest regulatory filings, with 10 funds opening new positions, 3 increasing their positions, 6 reducing their positions, and 8 closing their positions.

New
Increased
Maintained
Reduced
Closed

25% more first-time investments, than exits

New positions opened: 10 | Existing positions closed: 8

6% more funds holding

Funds holding: 33 → 35 (+2)

12% less capital invested

Capital invested by funds: $6.68M → $5.89M (-$791K)

50% less repeat investments, than reductions

Existing positions increased: 3 | Existing positions reduced: 6

Holders
35
Holders Change
+2
Holders Change %
+6.06%
% of All Funds
0.8%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
10
Increased
3
Reduced
6
Closed
8
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
PM
Prosight Management
Texas
+$1.26M
2
Point72 Asset Management
Point72 Asset Management
Connecticut
+$933K
3
AIC
AWM Investment Company
New York
+$248K
4
Renaissance Technologies
Renaissance Technologies
New York
+$123K
5
WVP
Worth Venture Partners
New Jersey
+$86.5K

Top Sellers

Rank Fund Capital Flow
1
Adage Capital Partners
Adage Capital Partners
Massachusetts
-$1.16M
2
SM
Sabby Management
Florida
-$574K
3
BCM
Bridgeway Capital Management
Texas
-$207K
4
D.E. Shaw & Co
D.E. Shaw & Co
New York
-$112K
5
ERSOT
Employees Retirement System of Texas
Texas
-$81K
Name Holding Trade Value Shares
Change 		Change in
Stake
EP
26
Elkfork Partners
Oregon
$4K +$4.81K +2 New
Morgan Stanley
27
Morgan Stanley
New York
$3K -$2.4K -1 -33%
MCIM
28
Meadow Creek Investment Management
Georgia
$3K +$2.4K +1 New
GHCM
29
Glen Harbor Capital Management
California
$3K +$4.81K +2 New
Federated Hermes
30
Federated Hermes
Pennsylvania
$2K – – –
JP Morgan Chase
31
JP Morgan Chase
New York
$2K – – –
FCM
32
Flinton Capital Management
Pennsylvania
$2K +$2.4K +1 New
MAM
33
Meeder Asset Management
Ohio
$1K -$4.81K -2 Closed
Bank of America
34
Bank of America
North Carolina
$1K – – –
BWM
35
Baystate Wealth Management
Massachusetts
$1K – – –
Citigroup
36
Citigroup
New York
$1K – – –
TCOV
37
Trust Company of Vermont
Vermont
$1K – – –
Fidelity Investments
38
Fidelity Investments
Massachusetts
$1K +$2.4K +1 New
RE
39
RBC Europe
United Kingdom
$73 – – –
Adage Capital Partners
40
Adage Capital Partners
Massachusetts
– -$1.16M -438 Closed
D.E. Shaw & Co
41
D.E. Shaw & Co
New York
– -$112K -42 Closed
ERSOT
42
Employees Retirement System of Texas
Texas
– -$81K -31 Closed
VF
43
Virtu Financial
New York
– -$21K -8 Closed
TRCT
44
Tower Research Capital (TRC)
New York
– -$16K -6 Closed
EAM
45
Eagle Asset Management
Florida
– -$9K -4 Closed
TIM
46
Tortoise Investment Management
New York
– -$3K -1 Closed
UBS Group
47
UBS Group
Switzerland
– -$1K – –
1
2

TPST Hedge Fund Activity: Q3 2018 in Review

35 of the 4,374 institutional investors tracked by Wall St. Rank reported a position in Tempest Therapeutics (TPST) for Q3 2018, worth a combined $5.89M — down 12% from $6.68M a quarter earlier.

Buyers outnumbered sellers: 10 funds opened new TPST positions and 8 closed out — a net gain of 2 holders — while 3 added to existing stakes and 6 trimmed.

The largest buyer was Prosight Management, opening a new position worth an estimated $1.26M. The largest seller was Adage Capital Partners, exiting entirely with an estimated $1.16M sold.

  • 35 institutional investors held Tempest Therapeutics (TPST) as of Q3 2018, up from 33 in Q2 2018.
  • Funds reported $5.89M of Tempest Therapeutics stock for Q3 2018, down 12% quarter-over-quarter.
  • 10 funds opened new Tempest Therapeutics positions in Q3 2018 and 8 closed out, a net change of +2 holders.
  • The largest Tempest Therapeutics buyer in Q3 2018 was Prosight Management, an estimated $1.26M added.
  • The largest Tempest Therapeutics seller in Q3 2018 was Adage Capital Partners, an estimated $1.16M sold.

Based on aggregated 13F filings for Q3 2018.